Rubius Therapeutics Taps Dannielle Appelhans as Chief Operating Officer

By Robb M. Stewart

Rubius Therapeutics Inc. Thursday named Dannielle Appelhans as chief operating officer to oversee corporate strategy and technical operations.

The appointment is effective Aug. 9, the clinical-stage biopharmaceutical company said.

Most recently, Ms. Appelhans was senior vice president of technical operations and chief technical officer at Novartis Gene Therapies, where she oversaw late-stage development, clinical and commercial manufacturing, supply chain and all supporting operational functions for the gene therapy unit and AAV portfolio Rubius. Prior to joining Novartis, she was a senior engagement manager at McKinsey & Co. in its pharmaceutical operations practice, and earlier in her career she held roles at Eli Lilly & Co.

Write to Robb M. Stewart at [e-mail]

(END) Dow Jones Newswires

07-29-21 0906ET